3rd Generation In Homoeopathy Arthrit Indica Tablet

Foreign Product Alert
2008-102
June 30, 2008
For immediate release

Health Canada is advising consumers not to use the products specified below due to concerns about possible side-effects. More info

Date of alert: June 30, 2008
Source of Alert: Health Sciences Authority of Singapore
Product Names: 3rd Generation In Homoeopathy Arthrit Indica Tablet
Manufacturer / Place of Origin: Abu Bakar & Osman Trading, Singapore

Product Description
Product label promotes use for "intense joint pain."

Reason for Warning
Arthrit Indica Tablets contain nimesulide, a pharmaceutical ingredient that is not authorized for sale in Canada. Nimesulide has been withdrawn from the market in several countries due to an association with liver damage.

Possible Side-Effects
Use of nimesulide has been associated with liver damage.

-30-

Media Inquiries:
Health Canada
(613) 957-2983

For more details on these Foreign Product Alerts, please visit the Health Canada Web site.

---

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find any of the products listed above in the Canadian marketplace.

For more information about the information contained in this advisory, please contact Health Canada's public inquiries line at (613) 957-2991 or toll-free at 1-866-225-0709.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.